Found 11 matching trials
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis PHASE3 The purpose of this study is to find out how well and safely elafibranor wo...
Show More Location
Arizona Liver Health
Learn More & Join Trial
Elafibranor Pharmacokinetic Parameters in Elderly Healthy Volunteers PHASE1 In the elderly, pharmacokinetics is altered. Gastric juice pH is elevated w...
Show More Learn More & Join Trial
Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH) PHASE2 The study was being conducted in order to assess the pharmacokinetics and t...
Show More Location
University of California
Learn More & Join Trial
Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients PHASE1 This study is being conducted in order to assess the need for dose adjustme...
Show More Learn More & Join Trial
Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505 PHASE1 The Sponsor, Genfit, has developed a new formulation of GFT505 (60 mg). The...
Show More Location
SGS Aster S.A.S. - Phase I Clinical Unit
Learn More & Join Trial
Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients PHASE1 This study is being conducted in order to assess the need for dose adjustme...
Show More Location
Division of Clinical Pharmacology, University of Miami
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid PHASE2 The primary objective of the study is to compare the effect of daily oral a...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Phase I Study to Evaluate the Effect of GFT505 on QT/QTc Interval in Healthy Volunteers PHASE1 In accordance with International Conference on Harmonisation (ICH) E14 guid...
Show More Learn More & Join Trial
A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. PHASE2 This study will evaluate the effects of elafibranor (the study drug) in par...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Mass Balance Study of 14C-labelled GFT505 in Healthy Volunteers PHASE1 Human mass-balance studies with radiolabelled study drug are needed to eval...
Show More Location
SGS Life Science Services
Learn More & Join Trial